Species-related pharmacological heterogeneity of histamine H3 receptors

被引:48
作者
Ireland-Denny, L [1 ]
Parihar, AS [1 ]
Miller, TR [1 ]
Kang, CH [1 ]
Krueger, KM [1 ]
Esbenshade, TA [1 ]
Hancock, AA [1 ]
机构
[1] Abbott Labs, Dept R4MN, Abbott Pk, IL 60064 USA
关键词
histamine H-3 receptor; receptor heterogeneity; radioligand binding; ileum; guinea pig; electrical field stimulation;
D O I
10.1016/S0014-2999(01)01518-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We compared radioligand binding and functional data for histamine H-3 receptor ligands across different tissues or species to evaluate the basis for pharmacological evidence of receptor heterogeneity previously reported. Agonist binding affinities showed correlation coefficients near unity in comparing human, dog, rat, and guinea pig cerebral cortical histamine H-3 receptors. Antagonist binding affinities revealed lower correlations fur human compared to dog, rat, or guinea pig, suggesting species-based pharmacological differences. The functional potencies of histamine H-3 receptor antagonists in field-stimulated guinea pig ileum were highly correlated to binding affinities for guinea pig, dog, and, to a lesser extent, rat cerebral cortex. However, antagonist binding affinity at human cerebral cortex did not correlate well with guinea pig ileum functional potency, These results suggest significant interspecies histamine H-3 receptor heterogeneity, consistent with recent receptor gene sequence data. Therefore, genetic heterogeneity, rather than peripheral and central histamine H-3 receptor diversity, is responsible for the pharmacological differences observed. (C), 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 44 条
[1]   [H-3]-thioperamide as a radioligand for the histamine H-3 receptor in rat cerebral cortex [J].
AlvesRodrigues, A ;
Leurs, R ;
Wu, TS ;
Prell, GD ;
Foged, C ;
Timmerman, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) :2045-2052
[2]   AUTO-INHIBITION OF BRAIN HISTAMINE-RELEASE MEDIATED BY A NOVEL CLASS (H-3) OF HISTAMINE-RECEPTOR [J].
ARRANG, JM ;
GARBARG, M ;
SCHWARTZ, JC .
NATURE, 1983, 302 (5911) :832-837
[3]   HISTAMINE H-3 RECEPTOR-BINDING SITES IN RAT-BRAIN MEMBRANES - MODULATIONS BY GUANINE-NUCLEOTIDES AND DIVALENT-CATIONS [J].
ARRANG, JM ;
ROY, J ;
MORGAT, JL ;
SCHUNACK, W ;
SCHWARTZ, JC .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (4-5) :219-227
[4]   HIGHLY POTENT AND SELECTIVE LIGANDS FOR HISTAMINE RECEPTORS-H-3 [J].
ARRANG, JM ;
GARBARG, M ;
LANCELOT, JC ;
LECOMTE, JM ;
POLLARD, H ;
ROBBA, M ;
SCHUNACK, W ;
SCHWARTZ, JC .
NATURE, 1987, 327 (6118) :117-123
[5]   PHARMACOLOGICAL PROFILE OF NEW THIOPERAMIDE DERIVATIVES AT HISTAMINE PERIPHERAL H1-RECEPTORS, H2-RECEPTORS, H3-RECEPTORS IN GUINEA-PIG [J].
BAROCELLI, E ;
BALLABENI, V ;
CARETTA, A ;
BORDI, F ;
SILVA, C ;
MORINI, G ;
IMPICCIATORE, M .
AGENTS AND ACTIONS, 1993, 38 (3-4) :158-164
[6]  
Cassar S, 2000, NEUROREPORT, V11, pL3
[7]   HISTAMINE H-3 RECEPTORS MODULATE THE RELEASE OF [H-3] ACETYLCHOLINE FROM SLICES OF RAT ENTORHINAL CORTEX - EVIDENCE FOR THE POSSIBLE EXISTENCE OF H-3 RECEPTOR SUBTYPES [J].
CLAPHAM, J ;
KILPATRICK, GJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) :919-923
[8]  
CORUZZI G, 1991, J PHARMACOL EXP THER, V258, P325
[9]  
Drutel G, 2001, MOL PHARMACOL, V59, P1
[10]  
FINK K, 1990, N-S ARCH PHARMACOL, V342, P513